Page 76 - CIBERESP-2015-eng

Research groups
Group 14
Programme: Epidemiology and Control of Chronic Diseases Lead Researcher: Gestal Otero, Juan Jesús
Group Members
STAFF MEMBERS: Piñeiro Lamas, María.
ASSOCIATED MEMBERS: Barros Dios, Juan Miguel | Caamaño Isorna, Francisco | Figueiras Guzmán, Adolfo | Montes Martínez, Agustín | Pérez Ríos, Mónica | Ruano Raviña, Alberto | Saulyte, Jurgita | Smyth Chamosa, Ernesto | Takkouche Souilamas, El Bahi | Taracido Trunk, Margarita.
Main lines of research
• Banal diseases. This research line aims to ana- lyze the role of environmental and genetic expo- sure factors, as well as the interaction of both the increased risk of disease or very frequent symp- toms, without extreme gravity but with high im- pact on quality of life and economy. Among these pathologies are the common cold, aphthous sto- matitis, headaches, allergic rhinitis, dysmenor- rhea and premenstrual syndrome. The objective in the next years is to study the determinant of the most common symptom: pain.
• Cancer Epidemiology. Our group has made sig- nificant progress in the cancer epidemiology in recent years, especially in cancers related to environmental factors. We intend to determine whether exposure to residential radon influences other cancers apart from lung cancer and on the biological mechanisms through what the resi- dential radon can cause lung cancer. We intend
•
to go deeper and broader in the national multi- center study LCRINS (Lung Cancer Risk in Nev- er Smokers) and to maximize the services of the Radon Laboratory of Galicia, the only residential radon laboratory recognized by the Nuclear Safe- ty Council of northwest of Spain.
Pharmacoepidemiology. research line has iden- tified important determinants for prescribing, dis- pensing, and reporting of adverse drug reactions. Currently we have implemented three large-scale community trials to identify and to modify asso- ciated factors with poor prescribing/dispensing/ use of antibiotics in order to reduce their resist- ances. We are also developing studies to further identify the genetic factors of adverse reactions to drugs most relevant from the point of view of public health, such as gastrointestinal bleeding.
Technology assessment and health services. Our group aims to provide support within a consolidat-
76 I Annual report 2015 I CIBERESP
•